MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.330
-0.010 (-0.75%)
Jul 31, 2026, 4:00 PM EDT - Market closed
MediciNova Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, MediciNova stock has a consensus rating of "Strong Buy" and an average price target of $9.00. The average 1-year stock price forecast is 576.69% higher than the current stock price, while the lowest is $6.00 (+351.13%) and the highest is $11 (+727.07%).
Price Target: $9.00 (+576.69%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MediciNova stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 2 | 2 | 2 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 4 | 4 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $6 | Buy | Maintains | $6 | +351.13% | Jul 23, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $10 | Buy | Maintains | $10 | +651.88% | Jul 15, 2026 |
Financial Forecast
Revenue This Year
443.50K
from 409.66K
Increased by 8.26%
Revenue Next Year
400.00K
from 443.50K
Decreased by -9.81%
EPS This Year
-0.26
from -0.24
EPS Next Year
-0.43
from -0.26
EPS and Forward PE are based on non-GAAP adjusted numbers.